ABSTRACT
Background Post-stroke aphasia (PSA) recovery shows high variability across individuals and at different moments during recovery. Although diffusion biomarkers from the ventral and dorsal streams have demonstrated strong predictive power for language outcomes, it is still unclear how these biomarkers relate to the various stages of PSA recovery. In this study, we aim to compare diffusion metrics and language measures as predictors of language recovery in a longitudinal cohort of participants with PSA.
Methods Twenty-four participants (mean age = 73 years, 8 women) presenting PSA were recruited in an acute stroke unit. Participants underwent diffusion MRI scanning and language assessment within 3 days (acute phase) after stroke, with a behavioral follow-up at subacute (10±3 days) and chronic phases (> 6 months). We used regression analyses on language performance (cross-sectional) and Δscores at subacute and chronic timepoints (difference between acute and subacute, and subacute and chronic respectively), with language baseline scores, diffusion metrics from language-related white matter tracts, lesion size and demographic predictors.
Results Best prediction model of performance scores used axial diffusivity (AD) from the left arcuate fasciculus (AF) in both subacute (R2 = 0.785) and chronic timepoints (R2 = 0.626). Moreover, prediction of change scores depended on AD from left inferior frontal-occipital fasciculus (IFOF), in subacute stage (R2 = 0.5), and depended additionally on AD from right IFOF in the chronic stages (R2 = 0.68). Mediation analyses showed that lesion load of left AF mediated the relationship between AD from left AF and chronic language performance.
Conclusion Language performance in subacute and chronic timepoints depends on the integrity of left AF, whereas Δscores of subacute and chronic phases depends on left IFOF, showing a dissociation of the white matter pathways regarding language outcomes. These results support the hypothesis of a functional differentiation of the dual-stream components in PSA recovery.
Competing Interest Statement
AD received research grants from Canopy Growth and Eisai, served on scientific advisory boards for Eisai, Jazz Pharma and Eisai, as well as honoraria from speaking engagements from Jazz Pharma and Paladin Labs. The remaining authors do not have any conflict of interest to declare.
Funding Statement
This project was funded by a grant-in-aid from the Heart and Stroke Foundation (G-16-00014039 and G-19-0026212) as well as a project grant from the Canadian Institutes of Health Research (CIHR 470371) to K.M., A.D. and S.M.B. K.M. holds a Career Award from the "Fonds de Recherche du Québec Santé. A.O.G. holds a Fonds de Recherche du Québec Santé scholarship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for this study was obtained by the Ethics Committee at CIUSSS-NIM ((#MP-32-2018-1478)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data is available upon contact and consideration with the corresponding author.